Progenics Pharma (PGNX) Misses Q3 EPS by 3c

November 7, 2016 7:56 AM EST
Get Alerts PGNX Hot Sheet
Trade PGNX Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Progenics Pharma (NASDAQ: PGNX) reported Q3 EPS of $0.52, $0.03 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $53.9 million versus the consensus estimate of $52.9 million.

For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment